Vitrolife AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VTRLY research report →
Companywww.vitrolife.com
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors.
- CEO
- Bronwyn Brophy O'Connor
- IPO
- 2016
- Employees
- 1,150
- HQ
- Gothenburg, SE
Price Chart
Valuation
- Market Cap
- $1.49B
- P/E
- -2.97
- P/S
- 4.37
- P/B
- 1.84
- EV/EBITDA
- -3.41
- Div Yield
- 1.00%
Profitability
- Gross Margin
- 51.41%
- Op Margin
- 18.04%
- Net Margin
- -147.21%
- ROE
- -47.11%
- ROIC
- 5.74%
Growth & Income
- Revenue
- $3.44B · -4.68%
- Net Income
- $-4,711,229,716 · -1018.37%
- EPS
- $-34.79 · -1017.94%
- Op Income
- $579.03M
- FCF YoY
- -62.17%
Performance & Tape
- 52W High
- $18.55
- 52W Low
- $9.50
- 50D MA
- $11.00
- 200D MA
- $13.96
- Beta
- 1.73
- Avg Volume
- 4
Get TickerSpark's AI analysis on VTRLY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VTRLY Coverage
We haven't published any research on VTRLY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VTRLY Report →